Agios Pharmaceuticals AGIO Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's common stock, par value (in dollars per share)?
- Agios Pharmaceuticals (AGIO) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Agios Pharmaceuticals's common stock, par value (in dollars per share) changed year-over-year?
- Agios Pharmaceuticals's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Agios Pharmaceuticals's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.